Suppr超能文献

影像学和生理学引导下无造影剂的经皮冠状动脉介入治疗在晚期肾衰竭患者中的可行性、安全性及疗效研究

Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study.

作者信息

Ali Ziad A, Karimi Galougahi Keyvan, Nazif Tamim, Maehara Akiko, Hardy Mark A, Cohen David J, Ratner Lloyd E, Collins Michael B, Moses Jeffrey W, Kirtane Ajay J, Stone Gregg W, Karmpaliotis Dimitri, Leon Martin B

机构信息

Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA

Cardiovascular Research Foundation, New York, NY, USA.

出版信息

Eur Heart J. 2016 Oct 21;37(40):3090-3095. doi: 10.1093/eurheartj/ehw078. Epub 2016 Mar 7.

Abstract

AIMS

The feasibility, safety, and clinical utility of percutaneous coronary intervention (PCI) without radio-contrast medium in patients with advanced chronic kidney disease (CKD) are unknown. In this series, we investigated a specific strategy for 'zero contrast' PCI with the aims of preserving renal function and preventing the need for renal replacement therapy (RRT) in patients with advanced CKD.

METHODS AND RESULTS

A total of 31 patients with advanced CKD [creatinine = 4.2 mg/dL, inter-quartile range (IQR) 3.1-4.8, estimated glomerular filtration rate = 16 ± 8 mL/min/1.73 m] who had clinical indication for PCI based on a prior minimal contrast coronary angiogram were included. Zero contrast PCI was performed at least 1 week after diagnostic angiography using real-time intravascular ultrasound (IVUS) guidance, with pre- and post-PCI measurements of fractional flow reserve and coronary flow reserve to confirm physiological improvement. This approach resulted in successful PCI, no major adverse cardiovascular events and preservation of renal function without the need for RRT within a follow-up time of 79 days (IQR 33-207) in all patients.

CONCLUSION

In patients with advanced CKD who require revascularization, PCI may safely be performed without contrast using IVUS and physiological guidance with high procedural success and without complications.

摘要

目的

对于晚期慢性肾脏病(CKD)患者,不使用放射性造影剂进行经皮冠状动脉介入治疗(PCI)的可行性、安全性及临床实用性尚不清楚。在本系列研究中,我们探讨了一种“零造影剂”PCI的特定策略,旨在保护晚期CKD患者的肾功能并避免其需要肾脏替代治疗(RRT)。

方法与结果

共有31例晚期CKD患者[肌酐=4.2mg/dL,四分位数间距(IQR)3.1 - 4.8,估计肾小球滤过率=16±8mL/min/1.73m²]纳入研究,这些患者基于之前的最小造影剂冠状动脉造影有PCI的临床指征。在诊断性血管造影至少1周后,使用实时血管内超声(IVUS)引导进行零造影剂PCI,并在PCI前后测量血流储备分数和冠状动脉血流储备以确认生理改善情况。该方法在所有患者79天(IQR 33 - 207)的随访期内均成功完成PCI,无重大不良心血管事件,且肾功能得以保留,无需RRT。

结论

对于需要血运重建的晚期CKD患者,使用IVUS和生理指标引导,不使用造影剂进行PCI可能安全可行,手术成功率高且无并发症。

相似文献

引用本文的文献

9
Imaging in Percutaneous Coronary Intervention.经皮冠状动脉介入治疗中的影像学
Rev Cardiovasc Med. 2022 May 31;23(6):204. doi: 10.31083/j.rcm2306204. eCollection 2022 Jun.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验